510(k)
K222129: Nitrile Examination Powder Free Glove, Blue Tested For Use With 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim, Nitrile Examination Powder Free Glove, Black Tested For Use With 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim
FDA 510(k) · Top Glove Medical (Thailand) Co., Ltd. · decided Feb 10, 2023
Key facts
| 510(k) number | K222129 |
|---|---|
| Device name | Nitrile Examination Powder Free Glove, Blue Tested For Use With 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim, Nitrile Examination Powder Free Glove, Black Tested For Use With 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim |
| Applicant | Top Glove Medical (Thailand) Co., Ltd. |
| Product code | LZA |
| Subsequent product codes | LZC, OPJ, QDO |
| Date received | Jul 18, 2022 |
| Decision date | Feb 10, 2023 |
| Decision | Substantially equivalent (SESE) |
| Submission type | Traditional |
| Review panel | General Hospital |
| Medical specialty | General Hospital |
At a glance
- None MAUDE adverse event reports
- None Recall events
- None UDI device identifiers (GUDID)
- None Predicate devices cited
- None Later submissions citing this device
- 1,000+ 510(k)s with this product code
- No 510(k) summary on file
- Yes 510(k) statement on file
- Not listed On the FDA AI-enabled device list
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
Reading a 510(k)
- Decision
- SESE means the FDA found the device substantially equivalent to its predicate, so it may be marketed in the United States.
- Predicates
- Each clearance cites one or more legally marketed devices; the chain of predicates shows where a technology came from.
- Product code
- The three-letter code sets the device type, class and regulation, and groups competing clearances.
- Summary or statement
- Applicants file either a 510(k) summary of the safety and effectiveness information or a statement that it is available on request.
About 510(k) premarket notifications
A 510(k) is a premarket submission made to the FDA to demonstrate that a device is substantially equivalent to a legally marketed predicate device.
Source: U.S. Food and Drug Administration (FDA), 510(k) Premarket Notification database · Source date: